a Department of Counseling Psychology , University of Wisconsin-Madison , Madison , WI , USA.
b Research Institute, Modum Bad Psychiatric Center , Vikersund , Norway.
Psychother Res. 2017 Jan;27(1):14-32. doi: 10.1080/10503307.2016.1249433.
Three recent meta-analyses have made the claim, albeit with some caveats, that cognitive-behavioral treatments (CBT) are superior to other psychotherapies, in general or for specific disorders (e.g., social phobia).
The purpose of the present article was to examine four issues in meta-analysis that mitigate claims of CBT superiority: (a) effect size, power, and statistical significance, (b) focusing on disorder-specific symptom measures and ignoring other important indicators of psychological functioning, (c) problems inherent in classifying treatments provided in primary studies into classes of treatments, and (d) the inclusion of problematic trials, which biases the results, and the exclusion of trials that fail to find differences among treatments.
When these issues are examined, the effects demonstrating the superiority of CBT are small, nonsignificant for the most part, limited to targeted symptoms, or are due to flawed primary studies.
Meta-analytic evidence for the superiority of CBT in the three meta-analysis are nonexistent or weak.
三项近期的荟萃分析声称,认知行为疗法(CBT)总体上或针对特定障碍(例如社交恐惧症)优于其他心理疗法,但存在一些限制。
本文旨在检查荟萃分析中减轻 CBT 优越性主张的四个问题:(a)效应大小、功效和统计显著性,(b)专注于特定障碍的症状测量,而忽略其他重要的心理功能指标,(c)将主要研究中提供的治疗方法分类为治疗方法类别的固有问题,以及(d)纳入有问题的试验,这会产生偏差结果,以及排除未能发现治疗方法之间差异的试验。
当检查这些问题时,证明 CBT 优越性的效果很小,大部分情况下不显著,仅限于有针对性的症状,或者归因于有缺陷的主要研究。
这三项荟萃分析中 CBT 优越性的荟萃分析证据不存在或薄弱。